PROCEPT BioRobotics Corp financial data

Symbol
PRCT on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
150 Baytech Drive, San Jose, California
State of incorporation
Delaware
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 2, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 812 % +2.63%
Quick Ratio 99.2 % -1.81%
Debt-to-equity 44.5 % -25.1%
Return On Equity -37.9 % +32.4%
Return On Assets -26.2 % +25.4%
Operating Margin -62.1 % +37.6%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.9M shares +14.7%
Common Stock, Shares, Outstanding 51.9M shares +14.6%
Entity Public Float 1.4B USD +40%
Common Stock, Value, Issued 0 USD
Weighted Average Number of Shares Outstanding, Basic 51.6M shares +14.3%
Weighted Average Number of Shares Outstanding, Diluted 51.6M shares +14.3%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 177M USD +73.7%
Cost of Revenue 79.9M USD +60.5%
Research and Development Expense 56.7M USD +43.1%
Operating Income (Loss) -110M USD -8.4%
Net Income (Loss) Attributable to Parent -104M USD +0.81%
Earnings Per Share, Basic -2.06 USD/shares +11.6%
Earnings Per Share, Diluted -2.06 USD/shares +11.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 214M USD +43%
Accounts Receivable, after Allowance for Credit Loss, Current 58.9M USD +77.6%
Inventory, Net 43.9M USD +2.88%
Assets, Current 322M USD +39.9%
Property, Plant and Equipment, Net 27.7M USD +69.2%
Operating Lease, Right-of-Use Asset 19.6M USD -9.18%
Other Assets, Noncurrent 1.09M USD +734%
Assets 374M USD +37.4%
Accounts Payable, Current 9.95M USD -0.86%
Contract with Customer, Liability, Current 6.55M USD +38.9%
Liabilities, Current 42.8M USD +19.2%
Contract with Customer, Liability, Noncurrent 517K USD
Operating Lease, Liability, Noncurrent 27.8M USD +2.61%
Other Liabilities, Noncurrent 479K USD
Liabilities 123M USD +5.17%
Accumulated Other Comprehensive Income (Loss), Net of Tax -1K USD +83.3%
Retained Earnings (Accumulated Deficit) -506M USD -25.8%
Stockholders' Equity Attributable to Parent 252M USD +61.5%
Liabilities and Equity 374M USD +37.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -32.3M USD +10.1%
Net Cash Provided by (Used in) Financing Activities 2.59M USD +581%
Net Cash Provided by (Used in) Investing Activities -1.95M USD +63.6%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 51.9M shares +14.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -31.6M USD +22.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 217M USD +41.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 1M USD -10.4%
Deferred Tax Assets, Valuation Allowance 121M USD +29.1%
Deferred Tax Assets, Gross 126M USD +26.6%
Operating Lease, Liability 29.6M USD +0.42%
Payments to Acquire Property, Plant, and Equipment 1.95M USD -63.6%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -104M USD +0.85%
Lessee, Operating Lease, Liability, to be Paid 42.9M USD -10.5%
Property, Plant and Equipment, Gross 33.6M USD +26.5%
Operating Lease, Liability, Current 1.77M USD -24.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 4.43M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.3M USD +2.73%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 13.3M USD -28%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.81M USD +8.63%
Deferred Tax Assets, Operating Loss Carryforwards 80.3M USD +23.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 3.39M USD +25.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.95M USD +3%
Additional Paid in Capital 758M USD +35.7%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 300K USD 0%
Depreciation, Depletion and Amortization 1.18M USD +49.3%
Deferred Tax Assets, Net of Valuation Allowance 4.96M USD -14.9%
Share-based Payment Arrangement, Expense 24.5M USD +64.3%
Interest Expense 4.15M USD -10.6%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%